Answers are grounded in this paper and cite their sources.
86 μM). This compound is therefore a useful tool for studies of cell cycle regulation. Crystal structures of inhibitor-kinase complexes showed that the inhibitor stabilizes a glycine-rich loop conformation that shapes the ATP ribose binding pocket and that is preferred in CDK2 but has not been observed in CDK1. This aspect of the active site may be exploited for the design of inhibitors that distinguish between CDK1 and CDK2.
No takes yet. Share an insight, caveat, or question.
Coxon et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: